| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/16/2013 | US8486895 Anti-epidermal growth factor receptor antibodies and uses thereof |
| 07/16/2013 | US8486893 Treatment of conditions involving demyelination |
| 07/16/2013 | US8486663 Compositions and methods for generating antibodies |
| 07/16/2013 | US8486657 Anti-preproprotein and anti-preprotein antibodies as immunohistochemical markers |
| 07/16/2013 | US8486641 Compositions and methods for diagnosing and treating prostate cancer |
| 07/16/2013 | US8486620 Polymeric carriers for immunohistochemistry and in situ hybridization |
| 07/16/2013 | US8486416 Use of SDF-1 to improve ischemic myocardial function |
| 07/16/2013 | US8486410 RLIP76 liposomes for protection against irradiation |
| 07/16/2013 | US8486405 Method for diagnosing and treating emphysema |
| 07/16/2013 | US8486404 Antibody specifically binding to angiopoietin-2 and use thereof |
| 07/16/2013 | US8486401 Monoclonal antibodies binding to TrkA and acting as NGF-antagonist molecules and their use for treating pain induced by NGF |
| 07/16/2013 | US8486400 Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling |
| 07/16/2013 | US8486395 Anti-CD19 antibodies |
| 07/16/2013 | US8486394 Generation and Profiling of fully human hucal gold-derived therapeutic antibodies specific for human CD38 |
| 07/16/2013 | US8486391 Cancer treatment kits using antibodies to aminophospholipids |
| 07/16/2013 | CA2660463C Antibodies to il-17a |
| 07/16/2013 | CA2591786C Prevention of thrombus formation and/or stabilization |
| 07/16/2013 | CA2512138C Kim-1 antagonists and use to modulate immune system |
| 07/16/2013 | CA2483980C Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/16/2013 | CA2425486C Flea peritrophin nucleic acid molecules, proteins and uses thereof |
| 07/16/2013 | CA2395406C Method for treating inflammation |
| 07/16/2013 | CA2384948C Therapies for chronic renal failure using one or more integrin antagonists |
| 07/16/2013 | CA2358684C Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/16/2013 | CA2330231C Composition and method for modulating dendritic cell-t cell interaction |
| 07/11/2013 | WO2013103800A1 Anti-transferrin receptor antibodies and methods using same |
| 07/11/2013 | WO2013102822A1 Filtration method |
| 07/11/2013 | WO2013102659A2 Binding agents to intracellular target molecules |
| 07/11/2013 | WO2013102492A1 Synthetic genes encoding peptide fragments of natural myelin proteins for induction of oral tolerance, dna fragment comprising these genes, means of obtaining these peptides in a microbial (bacterial) system and their medical application |
| 07/11/2013 | WO2013041844A3 Antibodies, variable domains & chains tailored for human use |
| 07/11/2013 | WO2013020090A3 STREPTOCOCCAL GLcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM |
| 07/11/2013 | WO2013001369A4 Therapeutic and diagnostic target |
| 07/11/2013 | US20130178607 Process for purifying proteins |
| 07/11/2013 | US20130178606 Recombinant protein capable of binding specifically and quickly to troponin i derived from human myocardium |
| 07/11/2013 | US20130178605 Hetero-Dimeric Immunoglobulins |
| 07/11/2013 | US20130178418 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 07/11/2013 | US20130178396 Focused libraries of genetic packages |
| 07/11/2013 | US20130177985 DNA Sequence Encoding a Retinoic Acid Regulated Protein |
| 07/11/2013 | US20130177982 Interleukin-1 Alpha Antibodies and Methods of Use |
| 07/11/2013 | US20130177944 Anti-cd4 antibody |
| 07/11/2013 | US20130177931 Soluble human st-2 antibodies and assays |
| 07/11/2013 | US20130177924 Linked peptide fluorogenic biosensors |
| 07/11/2013 | US20130177660 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof |
| 07/11/2013 | US20130177592 Immunization against clostridium difficile disease |
| 07/11/2013 | US20130177579 Anti-transferrin receptor antibodies and methods using same |
| 07/11/2013 | US20130177574 ANTI-HLA CLASS-Ib ANTIBODIES MIMIC IMMUNOREACTIVITY AND IMMUNOMODULATORY FUNCTIONS OF INTRAVENOUS IMMUNOGLOBULIN (IVIg) USEFUL AS THERAPEUTIC IVIg MIMETICS AND METHODS OF THEIR USE |
| 07/11/2013 | US20130177573 Anti-human respiratory syncytial virus (rsv) antibodies and methods of use |
| 07/11/2013 | US20130177572 Pdgf receptor beta binding polypeptides |
| 07/11/2013 | US20130177571 Anti-Mesothelin Antibodies |
| 07/11/2013 | US20130177570 Anti-human folate receptor beta antibodies and methods of use |
| 07/11/2013 | US20130177568 Blood-brain barrier permeable peptide compositions |
| 07/11/2013 | US20130177567 Novel c3c epitope, antibodies binding thereto, and use thereof |
| 07/11/2013 | US20130177565 Administering anti-placental growth factor antibodies |
| 07/11/2013 | US20130177564 Administering anti-placental growth factor antibodies |
| 07/11/2013 | US20130177558 Method of Treating Immunological Disorders by Administering Truncated BAFF Receptors |
| 07/11/2013 | US20130177557 Vista regulatory t cell mediator protein, vista binding agents and use thereof |
| 07/11/2013 | US20130177555 Monomeric Polypeptides Comprising Variant FC Regions And Methods Of Use |
| 07/11/2013 | US20130177553 Novel Compositions and Methods for Treating IgE-Mediated Disorders |
| 07/11/2013 | US20130177551 Risk markers for cardiovascular disease |
| 07/11/2013 | US20130177500 Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery |
| 07/11/2013 | DE112011102640T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung undPrävention von Infektionskrankheiten A pharmaceutical combination composition and methods for treating of infectious diseases undPrävention |
| 07/10/2013 | EP2612870A1 Recurrent gene fusions in prostate cancer |
| 07/10/2013 | EP2612869A2 The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases |
| 07/10/2013 | EP2612679A1 Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
| 07/10/2013 | EP2611928A1 Anti-c-met antibody and methods of use thereof |
| 07/10/2013 | EP2611834A1 Rapid generation of anti-idiotypic antibodies |
| 07/10/2013 | EP2611833A1 Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs |
| 07/10/2013 | EP2611832A2 Anti-cxcl13 antibodies and methods of using the same |
| 07/10/2013 | EP2611831A1 Treatment of myocardial infarction using tgf - beta antagonists |
| 07/10/2013 | EP2611830A1 Vegf-binding molecules |
| 07/10/2013 | EP2611829A2 Novel antigen binding proteins |
| 07/10/2013 | EP2611828A2 Staphylococcus aureus specific human recombinant polyclonal antibodies and uses thereof |
| 07/10/2013 | EP2611465A2 Human immunodeficiency virus (hiv)-neutralizing antibodies |
| 07/10/2013 | EP2611462A2 Peptide or peptide complex binding to 2 integrin and methods and uses involving the same |
| 07/10/2013 | EP2261376B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins |
| 07/10/2013 | CN1541109B Inhibitors of HER3 activity |
| 07/10/2013 | CN103201293A Methods for assessing and identifying or evolving conditionally active therapeutic proteins |
| 07/10/2013 | CN103201292A Treatment of myocardial infarction using TGF-[beta] antagonists |
| 07/10/2013 | CN103201291A Anti single-strand type-iv collagen polypeptide antibody, and pharmaceutical, or agent for diagnosing, preventing or treating tumours, containing same |
| 07/10/2013 | CN103201290A S100a4 antibodies and therapeutic uses thereof |
| 07/10/2013 | CN103201289A Anti-c5a antibodies and methods for using the antibodies |
| 07/10/2013 | CN103201288A Optimized method for antibody capturing by mixed mode chromatography |
| 07/10/2013 | CN103201287A Antibody molecules to oncogenic isoforms of fibroblast growth factor receptor-2 and uses thereof |
| 07/10/2013 | CN103201286A Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (alk) kinase inhibitors |
| 07/10/2013 | CN103201003A Purification of antibodies using simulated moving bed chromatography |
| 07/10/2013 | CN103200964A Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition |
| 07/10/2013 | CN103200963A Dual variable domain immunoglobulins and uses thereof |
| 07/10/2013 | CN103194476A Cloning and expression of partial fragment of chicken pcdh1 gene and preparation of polyclonal antibody |
| 07/10/2013 | CN103194430A Hybridoma capable of secreting anti-CA125 protein monoclonal antibody and application of hybridoma |
| 07/10/2013 | CN103193886A Use of mouse-anti-human T cell antigen ZCH-2B8alpha fluorescent-labeled monoclonal antibody |
| 07/10/2013 | CN103193885A Anti-EPHRINB2 antiboies and methods using same |
| 07/10/2013 | CN103193884A ELISA (enzyme-linked immuno sorbent assay) kit for detecting sterigmatocystin |
| 07/10/2013 | CN103193883A Method for synthesizing artificial antigen of specific ractopamine |
| 07/10/2013 | CN103193873A Immunogen for preparing antibodies used for identification of denatured Bt proteins, antibody prepared by same and application thereof |
| 07/10/2013 | CN103193870A Dengue virus degeneration vaccine and application thereof |
| 07/10/2013 | CN102492658B PSer86 monoclonal antibody of Tip60, as well as preparation method and application of pSer86 monoclonal antibody |
| 07/10/2013 | CN102137929B Anti-CDH3 antibodies labeled with radioisotope label and uses thereof |
| 07/10/2013 | CN102120768B Method for producing curative canine parvovirus virus monoclonal antibody by using bioreactor |
| 07/10/2013 | CN101891816B Humanized monoclonal antibody IgG Fab fragment of dermatophagoides farinae 2 allergoid specificity as well as preparation method and application thereof |
| 07/10/2013 | CN101885775B Preparation and enzyme-linked immunosorbent assay method for heavy metal mercury polyclonal antibody |